Invivyd (IVVD) EV/EBIT: History & Chart

Invivyd, Inc.(IVVD)

Biotechnology · New Haven, CT

$0.81-0.03 (-3.30%)

Delayed quote: Oct 6, 2026, 2:20 PM EDT

About Invivyd, Inc.

Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.

New Haven, CT

122 employees

www.invivyd.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Marc William Elia

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Invivyd, Inc. (IVVD)	$239.07M	N/A	N/A	N/A	N/A
Q32 Bio Inc. (QTTB)vs ›	$239.90M	6.47x	4.53x	4.53x	4.53x
High Tide Inc. (HITI)vs ›	$237.69M	99.44x	177.33x	172.45x	172.45x
Akebia Therapeutics, Inc. (AKBA)vs ›	$237.35M	N/A	245.87x	245.87x	245.87x
Galectin Therapeutics Inc. (GALT)vs ›	$242.02M	N/A	N/A	N/A	N/A
BioAge Labs Inc. (BIOA)vs ›	$236.06M	N/A	N/A	N/A	N/A
Utah Medical Products, Inc. (UTMD)vs ›	$235.97M	22.98x	12.07x	10.11x	11.81x
InflaRx N.V. (IFRX)vs ›	$235.67M	N/A	N/A	N/A	N/A
Lifecore Biomedical, Inc. (LFCR)vs ›	$242.50M	N/A	98.16x	1055.07x	378.93x
CAMP4 Therapeutics Corporation (CAMP)vs ›	$235.32M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Invivyd, Inc. (IVVD)

$239.07M

N/A

Q32 Bio Inc. (QTTB)vs ›

$239.90M

6.47x

4.53x

High Tide Inc. (HITI)vs ›